The Strategy Behind Your Journey to GMP with Emphasis on Linker Payload Development.

Published on April 4, 2022

Develop lower risk strategies with our insights into the key considerations you need to factor in when conjugating your linker payload to its antibody in our review of the pros and cons of semi-synthetic and synthetic linker payloads.

The post The Strategy Behind Your Journey to GMP with Emphasis on Linker Payload Development. appeared first on abzena.

Continue reading on website
Other news

Addressing Immunogenicity Challenges to Select the Best Drug Development Candidate.

April 4, 2022
De-risk and accelerate your programs by understanding some of the approaches to therapeutic protein immunogenicity risk assessment and how this helps you make better-informed candidate selection.The post Addressing Immunogenicity Challenges to Select the Best Drug Development Candidate. appeared first on abzena.

Collaborative Approaches Needed to Effectively Speed Up and Streamline Development.

April 4, 2022
Listen to the strategies used to effectively speed up and streamline development including insight into the collaborative approaches needed between functional areas and the compromises required.The post Collaborative Approaches Needed to Effectively Speed Up and Streamline Development. appeared first on abzena.